US4190573A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the isolation of the polyvalent proteinase inhibitor
Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1979-02-12
•
Granted: 1980-02-26
•
Expires: 1999-02-12
Abstract
Abstract What is disclosed is a method for the isolation of the polyvalent proteinase inhibitor from aqueous extracts of animal organs by adsorbing the inhibitor from its aqueous solutions at pH 0.5 to 10.5 on an ion exchanger containing functional sulfonate or phosphonate groups and eluting it with water or a salt solution at pH 1 to pH 13, the exchanger having a particle size from 0.03 to 0.08 mm or, in case the ion exchanger is a copolymer gel of ethene-sulfonate and acrylamide, having a particle size from 0.03 to 3 mm preferably from 0.06 to 0.3 mm.
Inventors
- 👤 Oswald Zwisler
- 👤 Gerhard Guthohrlein
- 👤 Hans-Heinrich Nau
- 👤 Helmut Rinno
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 08:55
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/81; C07K14/8107; C07K14/811; C07K14/8114; C07K14/8117; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/848
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
152 words
In a method for isolating polyvalent proteinase inhibitor, obtained by the aqueous extraction of animal organs, from an aqueous solution of said inhibitor, which method comprises contacting said aqueous solution with an acid ion exchanger to adsorb said inhibitor thereon and subsequently desorbing said inhibitor from said acid ion exchanger, the improvement wherein said aqueous solution of said inhibitor is contacted at a pH from 0.5 to 10.5 with an ion exchanger selected from the group consisting of polyphenol-ω-sulfonic acid, polystyrene sulfonic acid, and polystyrene phosphonic acid and having a particle size between 0.03 and 0.08 mm, or with an ion exchanger which is a copolymer of ethene sulfonate and acrylamide having a particle size between 0.03 and 3 mm, whereby said inhibitor is adsorbed on said ion exchanger, and said inhibitor is then eluted from said ion exchanger with water or a salt solution at a pH from 1 to 13.
Claim 2
Dependent Claim
152 words
In a method for isolating polyvalent proteinase inhibitor, obtained by the aqueous extraction of animal organs, from an aqueous solution of said inhibitor, which method comprises contacting said aqueous solution with an acid ion exchanger to adsorb said inhibitor thereon and subsequently desorbing said inhibitor from said acid ion exchanger, the improvement wherein said aqueous solution of said inhibitor is contacted at a pH from 0.5 to 10.5 with an ion exchanger selected from the group consisting of polyphenol-ω-sulfonic acid, polystyrene sulfonic acid, and polystyrene phosphonic acid and having a particle size between 0.03 and 0.08 mm, or with an ion exchanger which is a copolymer of ethene sulfonate and acrylamide having a particle size between 0.03 and 3 mm, whereby said inhibitor is adsorbed on said ion exchanger, and said inhibitor is then eluted from said ion exchanger with water or a salt solution at a pH from 1 to 13.
Claim 3
Dependent Claim
15 words
A method as in claim 1 wherein said ion exchanger is a polystyrene phosphonic acid.
Claim 4
Dependent Claim
14 words
A method as in claim 1 wherein said ion exchanger is a polyphenol-ω-sulfonic acid.
Claim 5
Dependent Claim
15 words
A method as in claim 1 wherein said ion exchanger is a polystyrene sulfonic acid.
Claim 6
Dependent Claim
19 words
A method as in claim 1 wherein said ion exchanger is a copolymer gel of ethene sulfonate and acrylamide.
Claim 7
Dependent Claim
53 words
A method as in claim 5 wherein said ion exchanger is a copolymer of ethene sulfonate and acrylamide in a weight ratio between 20:1 and 2:1, said copolymer is further cross-linked with 1 to 15 percent by weight of formaldehyde, and said ion exchanger has a grain size between 0.06 and 0.3 mm.
Claim 8
Dependent Claim
28 words
A method as in claim 5 wherein the inhibitor adsorbed on said ion exchanger is eluted therefrom with 10 percent sodium chloride solution at a pH of 3.0.
Claim 9
Dependent Claim
23 words
A method as in claim 1 wherein said inhibitor is eluted from said ion exchanger with water at a pH of about 12.5.
Claim 10
Dependent Claim
46 words
A method as in claim 1 wherein said ion exchanger is a member selected from the group consisting of polyphenol-ω-sulfonic acid, polystyrene sulfonic acid, and polystyrene phosphonic acid, and said inhibitor is eluted therefrom with a 20 percent sodium chloride solution at a pH of 7.0.
References Cited (Backward Citations)
US3002887A
Cited
US3003918A
Cited
US3181997A
Cited
DE1181371B
Cited
US3308026A
Cited
US3468760A
Cited
GB1134486A
Cited
US3558773A
Cited
GB1088214A
Cited
US3682835A
Cited
US3855196A
Cited
US3809748A
Cited
US3912704A
Cited
US3893890A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-02-25 | 1983-08-27 | 1984-02-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-02-25 | 1987-08-27 | 1988-02-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-02-25 | 1991-08-27 | 1992-02-26 | $7700.00 | Window Closed / Lapsed |